Cannae Holdings Acquires Minority Stake in JANA Partners

Apollo-Managed Funds Acquire 37% Minority Stake in Syntegon from CVC Capital Partners

March 23, 2026

Industrial Services

Apollo-managed funds have agreed to acquire an approximately 37% minority stake in industrial technology company Syntegon from CVC Capital Partners. CVC will retain a 63% majority stake as the partnership aims to accelerate Syntegon’s next growth phase, with particular focus on North America and unlocking service potential from Syntegon’s large installed systems base.

Miura Partners Acquires 20% Stake in Bianna to Launch Bianna Renting Services

May 23, 2024

Environmental Services

Miura Partners' Impact Fund acquired a 20% stake in Bianna through a capital increase to fund the company's expansion and to create Bianna Renting Services, a rental business for waste treatment equipment and turnkey solutions. Bianna, founded in 1990 and based in Girona, Spain, operates globally with four production centers and six commercial branches, employs over 200 people and reported revenues above €50 million in 2023.

Cannae Holdings and KDSA to Acquire Majority Stake in The Watkins Company

October 7, 2024

Food & Beverage

Cannae Holdings, Inc. will acquire a majority stake in The Watkins Company in partnership with KDSA Investment Partners. The transaction is expected to close in October 2024, and current majority owner/chairman Mark Jacobs will roll a significant equity stake into the deal.

Otsuka Pharmaceutical Acquires Jnana Therapeutics

August 1, 2024

Biotechnology

Otsuka Pharmaceutical Co., Ltd. will acquire clinical-stage biotech Jnana Therapeutics, making it a wholly owned subsidiary via Otsuka America, Inc. The deal values Jnana at $800 million in upfront cash plus up to $325 million in development and regulatory milestones and is intended to add Jnana's RAPID chemoproteomics platform and lead program JNT-517 (a potential oral PKU therapy) to Otsuka's specialty and autoimmune pipeline.

Trian Fund Management and General Catalyst Acquire Janus Henderson Group

December 22, 2025

Financial Services

Trian Fund Management and General Catalyst agreed to acquire Janus Henderson Group plc in an all-cash transaction, with the amended price increased to $52.00 per share ($7.4 billion equity value). The deal is expected to close in mid-2026, subject to customary closing conditions including regulatory approvals, client consents, and Janus Henderson shareholder approval.

Hempsana Holdings Ltd. Completes Acquisition of Hempsana Inc.

July 12, 2021

Pharmaceuticals

Hempsana Holdings Ltd. (formerly Stralak Resource Inc.) completed a previously announced three‑cornered amalgamation to acquire Hempsana Inc., making Hempsana a wholly‑owned subsidiary. The combined company will focus on manufacturing cannabis derivatives and extracts (including vapeables, topicals and infused consumables) from Hempsana's Health Canada standard processing licensed and EU‑GMP‑compliant facility; HHL's shares are expected to trade on the Canadian Securities Exchange under the ticker HMPS.